Jennison Associates LLC Acadia Pharmaceuticals Inc Transaction History

Jennison Associates LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$20.94 - $27.5 $1.22 Million - $1.6 Million	-58,139 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$16.79 - $27.09 $327,421 - $528,282	-19,501 Reduced 25.12%	58,139 $1.36 Million
Q3 2021 Nov 09, 2021	BUY	$15.78 - $24.77 $1.23 Million - $1.92 Million	77,640 New	77,640 $1.29 Million
Q1 2021 May 11, 2021	SELL	$25.02 - $54.99 $14.5 Million - $31.9 Million	-580,567 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$41.04 - $56.79 $17.6 Million - $24.3 Million	428,136 Added 280.87%	580,567 $31 Million
Q3 2020 Nov 04, 2020	BUY	$36.42 - $57.0 $22,143 - $34,656	608 Added 0.4%	152,431 $6.29 Million
Q2 2020 Aug 06, 2020	SELL	$39.26 - $52.73 $604,761 - $812,252	-15,404 Reduced 9.21%	151,823 $7.36 Million
Q1 2020 May 06, 2020	BUY	$31.65 - $46.87 $558,369 - $826,880	17,642 Added 11.79%	167,227 $7.07 Million
Q4 2019 Feb 07, 2020	BUY	$36.21 - $51.4 $5.42 Million - $7.69 Million	149,585 New	149,585 $6.4 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.